ZYX and neoplasm: The decreased F4/80+ macrophages and reduced tumor growth in Zyxin−/−;Irf3−/− mice (Fig. 7L–N) suggested that the enhanced antitumor immunity observed upon Zyxin depletion was at least partially independent of the TBK1-IRF3 axis.